Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
ribavirion 200 mg kapsel + interferon alfa-2b 3 MIE/injektionsvæske, opløsning, hætteglas |
Is a |
ribavirin + interferon alfa-2b |
false |
Inferred relationship |
Some |
|
|
ribavirion 200 mg kapsel + interferon alfa-2b 3 MIE/injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Cytokine |
false |
Inferred relationship |
Some |
|
|
ribavirion 200 mg kapsel + interferon alfa-2b 3 MIE/injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Interferon alfa-2b |
false |
Inferred relationship |
Some |
|
|
ribavirion 200 mg kapsel + interferon alfa-2b 3 MIE/injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
interferon alfa |
false |
Inferred relationship |
Some |
|
|
ribavirion 200 mg kapsel + interferon alfa-2b 3 MIE/injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ribavirin (substance) |
false |
Inferred relationship |
Some |
|
|
ribavirion 200 mg kapsel + interferon alfa-2b 3 MIE/injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
injektionsvæske |
false |
Inferred relationship |
Some |
|
|
ribavirion 200 mg kapsel + interferon alfa-2b 3 MIE/injektionsvæske, opløsning, hætteglas |
Has manufactured dose form |
Oral capsule |
false |
Inferred relationship |
Some |
|
|
ribavirion 200 mg kapsel + interferon alfa-2b 3 MIE/injektionsvæske, opløsning, hætteglas |
Is a |
Product manufactured as parenteral dose form (product) |
false |
Inferred relationship |
Some |
|
|
ribavirion 200 mg kapsel + interferon alfa-2b 3 MIE/injektionsvæske, opløsning, hætteglas |
Is a |
Ribavirin-containing product in oral dose form |
false |
Inferred relationship |
Some |
|
|
ribavirion 200 mg kapsel + interferon alfa-2b 3 MIE/injektionsvæske, opløsning, hætteglas |
Is a |
Ribavirin-containing product in parenteral dose form |
false |
Inferred relationship |
Some |
|
|